adenosine monophosphate has been researched along with Complications of Diabetes Mellitus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosino, I; Barbagelata, E; Ciarambino, T; Corbi, G; Moretti, AM; Politi, C | 1 |
| Agarwal, R; Bhalla, A; Chakrabarti, A; Garg, D; Kaur, H; Muthu, V; Puri, GD; Ramachandran, R; Sehgal, IS | 1 |
| Sabouret, P; Taiel-Sartral, M | 1 |
| Bell, RM; Cohen, MV; Downey, JM; Kunuthur, SP; Sivaraman, V; Yellon, DM | 1 |
| Bang, E; Jang, HJ; Kim, KH; Kim, Y; Lee, IS; Lee, JH; Na, YC; Park, J | 1 |
| Angiolillo, DJ; Bass, TA; Capodanno, D; Capranzano, P; Darlington, A; Desai, B; Dharmashankar, K; Ferreiro, JL; Guzman, LA; Rollini, F; Tello-Montoliu, A; Tomasello, SD; Ueno, M | 1 |
| Breslau, N; Moses, AM; Numann, PJ | 1 |
2 review(s) available for adenosine monophosphate and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Diabetes Complications; Glucocorticoids; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mucormycosis; Rhizopus; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
New antiplatelet agents in the treatment of acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Coronary Thrombosis; Diabetes Complications; Hemorrhage; Humans; Multicenter Studies as Topic; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Precision Medicine; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Renal Insufficiency; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome | 2014 |
5 other study(ies) available for adenosine monophosphate and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Gender differences in treatment of Coronavirus Disease-2019.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Amides; Antimalarials; Antiviral Agents; Cardiovascular Diseases; Chloroquine; Clinical Trials as Topic; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Diabetes Complications; Female; Humans; Hypertension; Immunity; Immunization, Passive; Immunoglobulins; Lopinavir; Male; Middle Aged; Mortality; Pandemics; Pyrazines; Ritonavir; SARS-CoV-2; Sex Characteristics | 2020 |
Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood.
Topics: Adenosine Monophosphate; Animals; Blood Platelets; Cardiotonic Agents; Diabetes Complications; Dose-Response Relationship, Drug; Humans; Male; Mice; Myocardial Ischemia; Myocardial Reperfusion Injury; Purinergic P2Y Receptor Antagonists; Rats; Rats, Inbred Strains; Receptors, Purinergic P2Y12 | 2015 |
Metabolic Profiling of Liver Tissue in Diabetic Mice Treated with Artemisia Capillaris and Alisma Rhizome Using LC-MS and CE-MS.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Alisma; Animals; Artemisia; Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Complications; Disease Models, Animal; Electrophoresis, Capillary; Fatty Liver; Lipid Metabolism; Liver; Male; Mass Spectrometry; Mice, Inbred C57BL; Plant Extracts; Purines | 2016 |
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation.
Topics: Adenosine Monophosphate; Aged; Coronary Artery Disease; Diabetes Complications; Female; Humans; Male; Middle Aged; Prospective Studies; Purinergic P2Y Receptor Antagonists; Treatment Outcome | 2013 |
Chlorpropamide-induced changes in patients with hyperparathyroidism.
Topics: Adenosine Monophosphate; Adult; Aged; Calcium; Chlorpropamide; Diabetes Complications; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Sodium | 1979 |